Ozempic and Wegovy maker Novo Nordisk now worth $500B amid soaring popularity
The drug maker vaulted ahead of luxury goods maker LVMH to claim the title of Europe's most valuable company.
The drug maker vaulted ahead of luxury goods maker LVMH to claim the title of Europe's most valuable company.